Clinical, Genomic, and Pharmacological Study of <em>MYCN</em>-Amplified <em>RB1</em> Wild-Type Metastatic Retinoblastoma

Clinical, Genomic, and Pharmacological Study of <em>MYCN</em>-Amplified <em>RB1</em> Wild-Type Metastatic Retinoblastoma

An uncommon subgroup of unilateral retinoblastomas with highly aggressive histological features, lacking aberrations in <i>RB1</i> gene with high-level amplification of <i>MYCN</i> (<i>MCYN</i><inline-formula><math display="inline"><semant...

Full description

Bibliographic Details
Main Authors:	Santiago Zugbi, Daiana Ganiewich, Arpita Bhattacharyya, Rosario Aschero, Daniela Ottaviani, Claudia Sampor, Eduardo G. Cafferata, Marcela Mena, Mariana Sgroi, Ursula Winter, Gabriela Lamas, Mariona Suñol, Manuel Daroqui, Edgardo Baialardo, Beatriz Salas, Anirban Das, Adriana Fandiño, Jasmine H. Francis, Fabiana Lubieniecki, Cinzia Lavarino, Ralph Garippa, Osvaldo L. Podhajcer, David H. Abramson, François Radvanyi, Guillermo Chantada, Andrea S. Llera, Paula Schaiquevich
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Cancers
Subjects:	metastatic retinoblastoma <i>MYCN</i> amplification wild-type <i>RB1</i> orbital dissemination
Online Access:	https://www.mdpi.com/2072-6694/12/9/2714

Internet

https://www.mdpi.com/2072-6694/12/9/2714